|
2025
|
P/S
|
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharm... |
|
|
Invention
|
Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis.
Aspects of the application provide... |
|
|
Invention
|
Enzyme compositions with reduced viral and microbial contamination.
The present invention pertai... |
|
|
P/S
|
Educational services, namely, conducting classes, workshops, training seminars, non-downloadable ... |
|
|
Invention
|
Tiparp inhibitor compounds. The present disclosure provides for compounds of Formula (I), and pha... |
|
|
Invention
|
Tiparp inhibitor compounds.
The present disclosure provides for compounds of Formula (I), and ph... |
|
|
Invention
|
Risankizumab compositions.
The present disclosure relates, in part, to risankizumab compositions... |
|
|
Invention
|
Methods of treatment using anti-sez6 antibody drug conjugates. The present application pertains t... |
|
|
Invention
|
Methods of treatment using anti-sez6 antibody drug conjugates.
The present application pertains ... |
|
|
Invention
|
Lpar1 inhibitors. Provided herein are compounds of Formula (I), compounds of Formula (II) and pha... |
|
|
Invention
|
Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)... |
|
|
Invention
|
Upadacitinib for use in the treatment of giant cell arteritis. The present disclosure is directed... |
|
|
Invention
|
Bispecific binding molecules.
The present disclosure provides novel bispecific molecules that bi... |
|
|
Invention
|
Anti-tau antibodies. The present disclosure provides anti-tau antibodies, including compositions ... |
|
|
Invention
|
Pharmaceutical formulations for subcutaneous administration.
The present disclosure relates to c... |
|
|
Invention
|
Pump, motor and assembly for beneficial agent delivery.
Pump includes a motor, a cam shaft coupl... |
|
|
Invention
|
Medication packaging and dispensing system.
A medication packaging and dispensing system is prov... |
|
|
Invention
|
Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3,-e]-pyrazin-8-yl... |
|
|
Invention
|
Clostridium botulinum neurotoxin serotype a compositions and improved drying processes. Clostridi... |
|
|
Invention
|
Clostridium botulinum neurotoxin serotype a compositions and improved drying processes.
Provided... |
|
|
Invention
|
Extended release upadacitinib formulations.
The disclosure describes extended release solid dosa... |
|
|
Invention
|
Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitor.
The presen... |
|
|
Invention
|
Processes for producing compositions with improved safety profile having lipase activity and comp... |
|
|
Invention
|
Lutikizumab for use in a treatment of hidradenitis suppurativa. The present disclosure relates to... |
|
2024
|
Invention
|
High concentration risankizumab formulations. The present disclosure relates to novel antibody fo... |
|
|
Invention
|
Salts and crystalline forms of an apoptosis-inducing agent.
Salts and crystalline forms of 4-(4-... |
|
|
Invention
|
Psma-steap1 dual variable domain immunogloblin (dvd-ig) molecules and drug conjugates.
The prese... |
|
|
Invention
|
Psma-steap1 dual variable domain immunoglobulin (dvd-ig) molecules and drug conjugates. The prese... |
|
|
Invention
|
Macrocyclic mcl-1 inhibitors and methods of use.
The present disclosure provides for compounds o... |
|
|
Invention
|
Clostridium botulinum neurotoxin serotype a compositions and improved filtration processes. Provi... |
|
|
Invention
|
Pyrimidines for degrading bruton's tyrosine kinase.
The present invention provides for compounds... |
|
|
Invention
|
Methods for treating spinal cord injury and pain.
Disclosed herein are anti-RGMa antibodies and ... |
|
|
Invention
|
Fused bicyclic compounds for the treatment of disease.
Described herein are fused bicyclic compo... |
|
|
Invention
|
Composition and method for the diagnosis and treatment of iron-related disorders.
Provided herei... |
|
|
Invention
|
Anti-egfr antibody drug conjugates.
The invention relates to anti-Epidermal Growth Factor Recept... |
|
|
Invention
|
Solid dispersions containing an apoptosis-inducing agent.
A pro-apoptotic solid dispersion compr... |
|
|
Invention
|
Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary ... |
|
|
Invention
|
Bcl-xl inhibitory compounds having low cell permeability and antibody drug conjugates including t... |
|
|
Invention
|
Anti-egfr antibody-drug conjugates.
The present disclosure relates to anti-Epidermal Growth Fact... |
|
|
Invention
|
Devices and methods for delivering a beneficial agent to a user.
A device for delivering a benef... |
|
|
Invention
|
Bromodomain inhibitors.
The present invention provides for compounds of formula (I)
The presen... |
|
|
Invention
|
Anti-egfr antibodies and antibody drug conjugates.
The invention relates to anti-epidermal growt... |
|
|
Invention
|
Methods of treating amyotrophic lateral sclerosis. The present disclosure provides herein, inter ... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musc... |
|
|
P/S
|
dietitian services in connection with clinical trials |
|
2023
|
P/S
|
Eye drops |
|
|
P/S
|
Ophthalmic preparations, namely, lubricant eye drops |
|
|
Invention
|
Carrying vest |
|
|
P/S
|
Providing medical information in the field of improving diversity and inclusion in clinical resea... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of glaucoma |
|
|
P/S
|
Providing a website featuring information in the field of the diagnosis and pharmaceutical treatm... |
|
|
Invention
|
Infusion pump |
|
2022
|
P/S
|
Pharmaceutical substances and preparations for the treatment of oncological diseases and disorders |
|
|
P/S
|
Pharmaceutical substances and preparations for the treatment of oncological diseases and disorders. |
|
|
P/S
|
pharmaceutical substances and preparations for the treatment of oncological diseases and disorders |
|
|
Invention
|
Process of making apoptosis-inducing agents.
Provided herein is a process for the preparation of... |
|
|
Invention
|
Protein tyrosine phosphatase targeting ligands.
Provided herein are compounds, compositions, and... |
|
|
P/S
|
Education services, namely conducting classes, workshops, training seminars, and discussion forum... |
|
2021
|
P/S
|
medical services; providing medical information; providing healthcare information to nurse practi... |
|
|
P/S
|
Administration of a discount program for medical patients featuring product savings programs, pro... |
|
2020
|
P/S
|
Charitable services, namely, patient assistance program to provide drugs free of charge to low-in... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of viral, namely herpes, hepatitis, ... |
|
|
P/S
|
pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musc... |
|
|
P/S
|
Pharmaceutical drug mail order services; pharmaceutical services, namely, processing online presc... |
|
|
P/S
|
mail order and online retail pharmacy services; pharmaceutical services, namely, processing of on... |
|
|
P/S
|
Providing medical information to patients and medical professionals in the form of reports in the... |
|
|
P/S
|
Printed matter, namely, pamphlets, brochures, newsletters, handouts, magazines, annual reports, b... |
|
2019
|
P/S
|
pharmaceutical preparations for the treatment of hepatitis C |
|
|
P/S
|
Providing medical information, namely, information regarding medical conditions, treatments and p... |
